A panel of federal health experts voted unanimously in favor of a new eye drug from Regeneron, bringing the company one step closer to competing against a blockbuster Roche drug that currently dominates the market.
Popular Posts:
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- FDA delays decision on lupus drug Benlysta